ResearcherKyorin UniversityActive in the last 2 years
Takahiro Shibayama
Matched on OpenAlex author ID A5157968859. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 4
- Molecular landscape of anaplastic transformation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/path.70136↗
- Diagnostic utility of MUC4 expression for distinguishing pancreatic ductal adenocarcinoma from extrahepatic cholangiocarcinoma and its clinicopathological sign… First author DOI 10.1016/j.humpath.2026.106137↗
- Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-13919-y↗
- Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-024-65900-w↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshihiro Sakamoto · 4 shared papers, 2024–2026 · strength 0.94
- Paper Diagnostic utility of MUC4 expression for distinguishing pancreatic ductal adenocarcinoma from extrahepatic cholangioca… DOI 10.1016/j.humpath.2026.106137↗
- Paper Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal ade… DOI 10.1038/s41598-025-13919-y↗
- Paper Molecular landscape of anaplastic transformation in pancreatic ductal adenocarcinoma. DOI 10.1002/path.70136↗
- Akimasa Hayashi · 4 shared papers, 2024–2026 · strength 0.94
- Paper Diagnostic utility of MUC4 expression for distinguishing pancreatic ductal adenocarcinoma from extrahepatic cholangioca… DOI 10.1016/j.humpath.2026.106137↗
- Paper Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal ade… DOI 10.1038/s41598-025-13919-y↗
- Paper Molecular landscape of anaplastic transformation in pancreatic ductal adenocarcinoma. DOI 10.1002/path.70136↗
- Junji Shibahara · 4 shared papers, 2024–2026 · strength 0.94
- Paper Diagnostic utility of MUC4 expression for distinguishing pancreatic ductal adenocarcinoma from extrahepatic cholangioca… DOI 10.1016/j.humpath.2026.106137↗
- Paper Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal ade… DOI 10.1038/s41598-025-13919-y↗
- Paper Molecular landscape of anaplastic transformation in pancreatic ductal adenocarcinoma. DOI 10.1002/path.70136↗
- Keiichiro Kitahama · 2 shared papers, 2024–2025 · strength 0.42
- Paper Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal ade… DOI 10.1038/s41598-025-13919-y↗
- Paper Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreat… DOI 10.1038/s41598-024-65900-w↗
- Christine A. Iacobuzio–Donahue · 2 shared papers, 2024–2026 · strength 0.40
- Saori Funakoshi · 1 shared paper, 2026 · strength 0.29
- Kaloyan M. Tsanov · 1 shared paper, 2026 · strength 0.23
- Scott W. Lowe · 1 shared paper, 2026 · strength 0.23
- Wungki Park · 1 shared paper, 2026 · strength 0.23
- Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.23
- Tadakazu Hisamatsu · 1 shared paper, 2024 · strength 0.17
- Naohiro Okano · 1 shared paper, 2024 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.